Helping older men with prostate cancer make decisions about surveillance
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
This study tests a new educational tool to help older men with localized prostate cancer decide if they should keep or change their active surveillance plan.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 180 (estimated) |
| Ages | 65 Years and up |
| Sex | Male |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06785441 on ClinicalTrials.gov |
What this trial studies
This study tests the effectiveness of an educational tool designed to assist older men with localized prostate cancer in making informed decisions about whether to continue or reduce active surveillance. The intervention aims to facilitate shared decision-making between patients and healthcare providers regarding the need for ongoing surveillance testing. By evaluating different versions of this decision aid, the study seeks to gather preliminary data that could inform future comparative studies.
Who should consider this trial
Good fit: Ideal candidates include males aged 65 or older who have localized prostate cancer and have not received curative treatment.
Not a fit: Patients currently undergoing treatment for another cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could empower patients to make more informed choices about their prostate cancer management, potentially reducing unnecessary procedures.
How similar studies have performed: Other studies have shown promise in using decision aids for cancer management, suggesting that this approach could be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients: 1. Males aged 65 or older 2. Diagnosis of localized prostate cancer 3. Have not received curative intent treatment for their prostate cancer 4. Fluent in English Care partners/caregivers: 1. Aged 18 or older 2. Fluent in English 3. Involved with the care of an eligible patient (i.e. partner, close friend, family member, companion) Exclusion Criteria: Patients 1\. Currently receiving treatment for another cancer (primary or recurrence) Care partners/caregivers 1\. None
Where this trial is running
Houston, Texas
- M.D. Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Lisa Lowenstein, MD — M.D. Anderson Cancer Center
- Study coordinator: Lisa Lowenstein, MD
- Email: deescalatepca@mdanderson.org
- Phone: 713-563-0020
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.